{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:59:14Z","timestamp":1790009954854,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:00:00Z","timestamp":1728086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101354","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:18:00Z","timestamp":1728501480000},"page":"101354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["An in\u00a0vitro and in\u00a0vivo efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPs"],"prefix":"10.1016","volume":"32","author":[{"given":"Vidyullatha","family":"Vasireddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey A.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Guilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Onieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leal-Juli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Verd\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M.E.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongGeun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpci\u00f3","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7553-5751","authenticated-orcid":false,"given":"Karen","family":"Kozarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101354_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omtm.2024.101354_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endrev\/bnaa013","article-title":"The Changing Face of Adrenoleukodystrophy","volume":"41","author":"Zhu","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.omtm.2024.101354_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.omtm.2024.101354_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020283","article-title":"Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy","volume":"11","author":"Mallack","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101354_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6786245","article-title":"Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease","volume":"2016","author":"Kawaguchi","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtm.2024.101354_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bbadis.2012.02.009","article-title":"Peroxisomal ABC transporters: structure, function and role in disease","volume":"1822","author":"Morita","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2024.101354_bib7","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/hmg\/ddt186","article-title":"Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy","volume":"22","author":"L\u00f3pez-Erauskin","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib8","first-page":"109","article-title":"The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis","volume":"8","author":"Wiesinger","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2024.101354_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","article-title":"X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects","volume":"1822","author":"Kemp","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2024.101354_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","article-title":"X-linked adrenoleukodystrophy in women: a cross-sectional cohort study","volume":"137","author":"Engelen","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2024.101354_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-020-01596-1","article-title":"Beyond gait and balance: urinary and bowel dysfunction in X-linked adrenoleukodystrophy","volume":"16","author":"Corre","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2024.101354_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","article-title":"International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach","volume":"99","author":"Engelen","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2024.101354_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2017.08.006","article-title":"Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies","volume":"122","author":"Adang","year":"2017","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2024.101354_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy","volume":"23","author":"Gong","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/hum.2018.079","article-title":"Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy","volume":"30","author":"Gong","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2024.101354_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson\u2019s disease: an open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2024.101354_bib19","doi-asserted-by":"crossref","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2024.101354_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/cgt.2009.8","article-title":"Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta","volume":"16","author":"Meijer","year":"2009","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s12035-015-9223-1","article-title":"A Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord","volume":"53","author":"Guo","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omtm.2024.101354_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib24","series-title":"Human Gene Therapy for Neurodegenerative Diseases: Guidance for Industry","year":"2022"},{"key":"10.1016\/j.omtm.2024.101354_bib25","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","article-title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy","volume":"13","author":"Pujol","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib26","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/brain\/aws292","article-title":"Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy","volume":"135","author":"L\u00f3pez-Erauskin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2024.101354_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1750-3639.2010.00390.x","article-title":"General aspects and neuropathology of X-linked adrenoleukodystrophy","volume":"20","author":"Ferrer","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.omtm.2024.101354_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","article-title":"Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy","volume":"11","author":"Pujol","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.26849","article-title":"Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans","volume":"95","author":"Gong","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2024.101354_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.955598","article-title":"Capacity of astrocytes to promote axon growth in the injured mammalian central nervous system","volume":"16","author":"Hemati-Gourabi","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2024.101354_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.expneurol.2016.03.009","article-title":"The multifaceted role of astrocytes in regulating myelination","volume":"283","author":"K\u0131ray","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtm.2024.101354_bib32","doi-asserted-by":"crossref","first-page":"a020370","DOI":"10.1101\/cshperspect.a020370","article-title":"Astrocytes Control Synapse Formation, Function, and Elimination","volume":"7","author":"Chung","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.omtm.2024.101354_bib33","first-page":"1135","article-title":"Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy","volume":"58","author":"Feigenbaum","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jmg.30.8.651","article-title":"Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy?","volume":"30","author":"Watkiss","year":"1993","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtm.2024.101354_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of intrathecal routes of administration for adeno-associated viral vectors in large animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101354_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2024.101354_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.omtm.2024.101354_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mtm.2013.7","article-title":"Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy","volume":"1","author":"Homs","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101354_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154597","article-title":"C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man","volume":"11","author":"van de Beek","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101354_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12747","article-title":"Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model","volume":"48","author":"Ranea-Robles","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.omtm.2024.101354_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/hgtb.2018.038","article-title":"Assessment of Humoral, Innate, and T-Cell Immune Responses to Adeno-Associated Virus Vectors","volume":"29","author":"Calcedo","year":"2018","journal-title":"Hum. Gene Ther. Methods"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T21:06:05Z","timestamp":1737666365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2329050124001700"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101354","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in\u00a0vitro and in\u00a0vivo efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101354"}}